Akanocure Pharmaceuticals Akanocure Pharmaceuticals is a drug development company with a focus on orphan and unmet needs in oncology. | ![]() Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. | ![]() Primmune Therapeutics Primmune Therapeutics is a company that provides drug design and development solutions. | ![]() ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ||
Founding Date | Founding Date 2014 | Founding Date 2007 | Founding Date 2017 | Founding Date 2020 | Founding Date 1981 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations West Lafayette, US HQ | Locations Bellaire, US HQ | Locations Carlsbad, US HQ | Locations Boston, US HQ Boston, US South San Francisco, US | Locations Waltham, US HQ |
Employees | Employees 2 | Employees 913% increase | Employees 1011% increase | Employees 1213% decrease | Employees 277161% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8.7 b |
Financial | |||||
Net income | Net income N/A | Net income ($9.9m) (FY, 2024) | Net income N/A | Net income N/A | Net income ($222.9m) (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7m (about 6 years ago) | Latest funding round $ 108m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 2.3m | Total funding raised $ 8.5m | Total funding raised $ 108m | Total funding raised $ 56m |

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View company
Primmune Therapeutics is a company that provides drug design and development solutions.
View company
Scorpion Therapeutics is a company that develops cancer treatments.
View company
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company